Please try another search
For the fiscal year ended 31 December 2021, Ensol Biosciences Inc. revenues decreased 37% to W368.8M. Net loss decreased 4% to W9.8B. Revenues reflect Overseas segment decrease of 92% to W30.2M. Lower net loss reflects Loss-Valt of Derivative Fincl Liab decrease of 47% to W1.35B (expense), Depreciation decrease of 31% to W81M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -W1168.06 to -W1030.33.
Period Ending: | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Total Revenue | 368.76 | 588.45 | 469.9 | 399.89 |
Gross Profit | 113.17 | 424.15 | 173.73 | 61.44 |
Operating Income | -8724.67 | -7609.87 | -5198.61 | -3823.49 |
Net Income | -9799.77 | -10167.2 | -4510.31 | -3801.47 |
Period Ending: | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Total Assets | 15388.31 | 12534.33 | 15654.51 | 8914.31 |
Total Liabilities | 17162.86 | 15483.85 | 13619.93 | 3022.4 |
Total Equity | -1774.55 | -2949.52 | 2034.58 | 5891.91 |
Period Ending: | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Period Length: | 12 Months | 12 Months | 12 Months | 12 Months |
Cash From Operating Activities | -6980.51 | -5074.35 | -4195.26 | -3139.48 |
Cash From Investing Activities | -3955.94 | 5336.2 | -6338.97 | -1814.41 |
Cash From Financing Activities | 10003.35 | 2310.82 | 10986.52 | 4731.48 |
Net Change in Cash | -923.47 | 2537.63 | 452.3 | -220.99 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review